Novel approach to block prostate cancer development identifiedNovember 25th, 2008 - 5:13 pm ICT by ANI
Washington, Nov 25 (ANI): Researchers from the University of Southern California (USC) have identified a novel approach that can block the development of prostate cancer.
In the study conducted using animal models has found that inactivating a specific protein associated with cancer development inhibits prostate tumour progression.
“This research has far-reaching implications in a wide range for human cancers,” said Amy Lee, Ph.D., the study’’s principal investigator and the associate director for basic research and holder of the Freeman Cosmetics Chair at the USC/Norris Comprehensive Cancer Center, and professor of biochemistry and molecular biology at the Keck School of Medicine of USC.
“It is a breakthrough study,” she added.
Lee said that the glucose-regulated protein GRP78 has been identified as a crucial entity in the development of prostate cancer by promoting cancer cell proliferation, mediating oncogenic signalling and protecting cancer cells against cell death resulting from the stress of tumor development.
By suppressing GRP78 expression or activity, the researchers found that they could block prostate cancer activation and development resulting from the loss of PTEN, a powerful tumour suppressor gene for a number of human cancers.
“To our knowledge, this is the first demonstration that inactivation of a specific molecular chaperone from the mouse prostate epithelial cells can potently block prostate cancer development and suppress the activation of AKT, which is a protein kinase that promotes cell proliferation and survival and is a major factor in many types of cancer,” she said.
“With the recent advances in identifying agents that suppress GRP78 expression, anti-GRP78 therapy may open up an entirely new approach to stop human cancer, she added.
The study appears in the Proceedings of the National Academy of Sciences. (ANI)
- Why PSA levels reflect prostate cancer progression - Jan 14, 2011
- How broccoli cuts prostate cancer risk - Jul 13, 2010
- Molecular predictor of metastatic prostate cancer identified - Feb 03, 2011
- Biomarkers for particularly aggressive prostate cancers discovered - Jul 13, 2010
- Now, prostate cancer can be inhibited without disturbing body processes - Aug 10, 2010
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- Mechanism that turns healthy cells into prostate cancer cells discovered - Dec 03, 2010
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Normal healthy breast cells can help kill cancer cells - Apr 14, 2011
- 'Longevity' protein may ward off precursor to prostate cancer - Jan 14, 2011
- Protein that protects against prostate cancer discovered - Feb 01, 2011
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- Pomegranate juice could be key to new cancer therapies - Dec 13, 2010
- New drug shrinks cancer, with few side effects - Apr 07, 2011
- Biophysicist attempts to block protein to prevent breast, prostate cancer - Apr 20, 2011
Tags: biochemistry and molecular biology, breakthrough study, cancer cell, cancer cells, cancer development, cell proliferation, comprehensive cancer center, epithelial cells, freeman cosmetics, grp78, human cancer, human cancers, keck school of medicine, molecular chaperone, national academy of sciences, norris comprehensive cancer center, proceedings of the national academy of sciences, protein kinase, southern california usc, university of southern california